Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Sex differences in the clinical and serologic presentation of early Lyme disease: Results from a retrospective review.

Schwarzwalder A, Schneider MF, Lydecker A, Aucott JN.

Gend Med. 2010 Aug;7(4):320-9. doi: 10.1016/j.genm.2010.08.002.

PMID:
20869632
2.

Serological responses in Lyme disease: the influence of sex, age, and environment.

Fidelus-Gort R, Gilmour RW, Kashatus WC.

Ann Clin Lab Sci. 1993 May-Jun;23(3):221-9.

PMID:
8323257
3.

Reactive Lyme serology in optic neuritis.

Sibony P, Halperin J, Coyle PK, Patel K.

J Neuroophthalmol. 2005 Jun;25(2):71-82.

PMID:
15937426
4.

Clinical evaluation of guidelines and two-test approach for lyme disease.

Blaauw AA, van Loon AM, Schellekens JF, Bijlsma JW.

Rheumatology (Oxford). 1999 Nov;38(11):1121-6.

PMID:
10556266
5.

The prevalence of Lyme disease in a nonendemic area. A comparative serologic study in a south Florida eye clinic population.

Smith JL, Parsons TM, Paris-Hamelin AJ, Porschen RK.

J Clin Neuroophthalmol. 1989 Sep;9(3):148-55.

PMID:
2529271
6.
7.

Development and laboratory evaluation of a new recombinant ELISA for the serodiagnosis of Lyme disease.

Hunfeld KP, Ernst M, Zachary P, Jaulhac B, Sonneborn HH, Brade V.

Wien Klin Wochenschr. 2002 Jul 31;114(13-14):580-5.

PMID:
12422605
8.
9.

Intralaboratory reliability of serologic and urine testing for Lyme disease.

Klempner MS, Schmid CH, Hu L, Steere AC, Johnson G, McCloud B, Noring R, Weinstein A.

Am J Med. 2001 Feb 15;110(3):217-9. No abstract available.

PMID:
11182109
10.

Impact of clinical variables on Borrelia burgdorferi-specific antibody seropositivity in acute-phase sera from patients in North America with culture-confirmed early Lyme disease.

Wormser GP, Nowakowski J, Nadelman RB, Visintainer P, Levin A, Aguero-Rosenfeld ME.

Clin Vaccine Immunol. 2008 Oct;15(10):1519-22. doi: 10.1128/CVI.00109-08. Epub 2008 Aug 20.

11.

The VlsE (IR6) peptide ELISA in the serodiagnosis of lyme facial paralysis.

Peltomaa M, McHugh G, Steere AC.

Otol Neurotol. 2004 Sep;25(5):838-41.

PMID:
15354020
12.

Facial nerve palsy in Lyme disease: evaluation of clinical diagnostic criteria.

Smouha EE, Coyle PK, Shukri S.

Am J Otol. 1997 Mar;18(2):257-61.

PMID:
9093686
13.

Western blotting in the serodiagnosis of Lyme disease.

Dressler F, Whalen JA, Reinhardt BN, Steere AC.

J Infect Dis. 1993 Feb;167(2):392-400.

14.

Use of western blot and enzyme-linked immunosorbent assays to assist in the diagnosis of Lyme disease.

Rose CD, Fawcett PT, Singsen BH, Dubbs SB, Doughty RA.

Pediatrics. 1991 Sep;88(3):465-70.

PMID:
1881724
15.

[Lyme's serology].

Armand-Lefevre L.

Ann Dermatol Venereol. 2003 Mar;130(3):385-7. Review. French. No abstract available.

PMID:
12746682
17.

Cross-reactivity in serological tests for Lyme disease and other spirochetal infections.

Magnarelli LA, Anderson JF, Johnson RC.

J Infect Dis. 1987 Jul;156(1):183-8.

PMID:
3298452
18.

Immunodiagnostic tests for Lyme disease.

Wilkinson HW.

Yale J Biol Med. 1984 Jul-Aug;57(4):567-72.

19.

Clinical and serologic features of Lyme borreliosis in Russia.

Ananjeva LP, Skripnikova IA, Barskova VG, Steere AC.

J Rheumatol. 1995 Apr;22(4):689-94.

PMID:
7791165
20.

Lyme disease surveillance in the United States, 1983-1986.

Ciesielski CA, Markowitz LE, Horsley R, Hightower AW, Russell H, Broome CV.

Rev Infect Dis. 1989 Sep-Oct;11 Suppl 6:S1435-41.

PMID:
2682955

Supplemental Content

Support Center